This ADC product is comprised of an anti-FOLH1 monoclonal antibody conjugated via a VC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF b
* VAT and and shipping costs not included. Errors and price changes excepted